Earnings And Financial PerformanceSales and profit metrics for SIBN were nicely ahead of expectations, suggesting strong performance.
Product InnovationSIBN has received FDA Breakthrough Device Designation for its new Pelvic Fracture Fixation System, exceeding launch expectations and making SIBN the only public company in its industry granted three BDDs.
Surgeon EngagementThere were more than 1,400 active surgeons in Q1, up 27%, marking the largest increase in any quarter ever.